A trial looking at surgery for ovarian cancer that has come back (DESKTOP 3)

Please note - this trial is no longer recruiting patients. We hope to add results when they are available.

Cancer type:

Ovarian cancer

Status:

Closed

Phase:

Phase 3

This trial is looking at chemotherapy and surgery for women with ovarian cancer that has come back (relapsed). This trial is supported by Cancer Research UK.

Doctors can treat ovarian cancer with surgery alone or surgery and chemotherapy. But sometimes the cancer starts to grow again. When this happens it can be more difficult to treat. Doctors usually treat ovarian cancer that has started to grow again with chemotherapy alone.

In this trial doctors want to find out if surgery and chemotherapy is better than chemotherapy alone for ovarian cancer that has come back.

The aims of this study are to find out

  • If surgery and chemotherapy is better than chemotherapy alone to treat ovarian cancer that has come back
  • The side effects

Who can enter

You may be able to enter this trial if you

You cannot enter this trial if you

  • Have a type of ovarian cancer known as non epithelial or borderline
  • Have had tummy (abdominal) surgery for any other cancer
  • Have a swollen tummy of fluid known as ascites Open a glossary item
  • Have had ovarian cancer that did not go away after treatment with platinum chemotherapy Open a glossary item
  • Have any medical condition that could make it unsafe for you to take part in this trial
  • Are taking any medication that could affect blood clotting, for example bevacizumab or warfarin

Trial design

This is a randomised trial. The women taking part are put into 2 treatment groups by a computer. Neither you nor your doctor will be able to decide which group you are in.

Women in one group have surgery to remove the cancer followed by chemotherapy. Women in the other group have chemotherapy alone.

Your doctor will decide which chemotherapy drugs are best for you and explain about the side effects.

The trial team will ask you to fill out a questionnaire before you start treatment and then 6 and 12 months later. The questionnaire will ask about side effects and how you have been feeling. This is called a quality of life study.

Hospital visits

You see the doctors and have some tests before you start treatment. The tests include

You see your cancer doctor and have tests often while you have treatment. These visits are not part of the trial and your doctor will explain them to you.

As part of the trial everyone has an interview with the researchers 60 days after starting chemotherapy.

They then have a blood test and physical examination

  • Every 3 months for 2 years
  • Every 6 months for 3 years
  • Once a year after that

Side effects

The most common side effects of surgery for ovarian cancer are

  • Bleeding
  • Pain
  • Problems with wound healing
  • Infection
  • Problems with digestion
  • Blood clots (DVT)

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Professor David Luesley

Supported by

Cancer Research UK
Cancer Research UK Clinical Trials Unit Birmingham
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUK/11/022

Questions about cancer? Contact our information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

Oracle 7397

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Around 1 in 5 people take part in clinical trials

3 phases of trials

Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think